Pharma reputation slips among patient advocacy groups, according to annual survey

Pa­tient ad­vo­ca­cy groups’ per­cep­tion of phar­ma com­pa­nies fell for the first time since be­gin­ning a steady rise five years ago, a sign that the in­dus­try may not be able to ful­ly hang on to the im­proved rep­u­ta­tion it’s en­joyed over the last sev­er­al years, ac­cord­ing to a new sur­vey.

The sur­vey from Pa­tientView as­sessed pa­tient groups’ opin­ions across 10 dif­fer­ent is­sues, in­clud­ing in­tegri­ty, trans­paren­cy, eq­ui­table ac­cess, pa­tient cen­tric­i­ty and high-qual­i­ty prod­ucts, and as­signed a per­cent­age score.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.